The frequency of A1298C and C677T polymorphisms of the methylentetrahydrofolate gene in Turkish patients with rheumatoid arthritis: Relationship with methotrexate toxicity

Open Rheumatology Journal

Volumn 5, Issue 1, 2011, Pages 30-35

  Taşbaş, Özgür ^a   Borman, Pinar ^a   Karabulut, Halil Gürhan ^b   Tükün, Ajlan ^b   Yorgancioǧlu, Rezan ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

A1298C polymorphism; C677T polymorphism; Folate; Methotrexate; MTHFR gene; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; GENOMIC DNA; HEMOGLOBIN; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG WITHDRAWAL; EAR DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FUNCTIONAL STATUS; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HEMATOLOGIC DISEASE; HOMOZYGOSITY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALAISE; MALE; METHYLENETATRAHYDROFOLATE REDUCTASE GENE; NAUSEA; NOSE DISEASE; PHARMACOGENETICS; PRIORITY JOURNAL; PSYCHOPATHY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SKIN DISEASE; SUPPLEMENTATION; THROAT DISEASE; TREATMENT DURATION; TURKEY (REPUBLIC); VOMITING;

EID: 80455158015     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901105010030     Document Type: Article

References (31)

1. th ed. Philadelphia, Mosby-Elsevier 2011; pp. 509-518.
2. Weisman MH, Furst DE, Park GS, et al. Risk genotypes in folate dependent enzymes and their association with methotrexate related side effects in rheumatoid arthritis. Arthritis Rheum 2006; 54: 607-612.
3. Stamp L, Roberts R, Kennedy M, Barclay M, O'Donnell J, Chapman P. The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics? Biomed Pharmacother 2006; 60: 678-687.
4. Taniguchi A, Kamatani N. Pharmacogenetic approaches to rheumatoid arthritis. Pharmacogenomics J 2004; 4: 350-353.
5. Evans WE. Differing effects of methylene tetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis. Pharmacogenetics 2002; 12: 181-182.
6. Ranganathan P, Culverhouse, Marsh S. Methotrexate gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 2008; 5: 559-569.
7. Fujimaki C, Hayashi H, Tsuboi S, et al. Plasma total homocysteine level and methylene tetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 2009; 14: 49-54.
8. Urano W, Taniguchi A, Yamanaka H, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics 2002; 12: 183-190.
9. Ghodke Y, Chopra A, Joshi K, Patwardhan B. Are thymidilate synthase and methylene tetrahydrofolate reductase genes linked with methotrextae response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients. Clin Rheumatol 2008; 27: 787-789.
10. Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med 2003; 11: 593-600.
11. Dervieux T, Greenstein N, Kremer J. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. Arthritis Rheum 2006; 54: 3095-3103.
12. Spelatos M, Papadopoulos N, Daiou C, Katodritou E, Pavlitou- Tsiontsi A, Galaropoulou V. Relationship between 5,10 metylene tetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation. Ann Rheum Dis 2005; 64: 1791-1792.
13. Aggarwal P, Naik S, Mishra KP, Aggarwal A, Misra R. Correlation between methotrexate efficacy and toxicity with C677T polymorphism of the methylene tatrahydrofolate gene in rheumatoid arthritis patients on folate supplementation. Indian Med J 2006; 124: 521-526.
14. Wessels J, Bouwstra J, Heijmans BT, et al. Efficacy and toxicity of methotrexate in early rheumatoid arhritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum 2006; 54: 1087-1095.
15. Grabar BP, Logar D, Lestan B, Dolzan V. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur J Clin Pharmacol 2008; 64: 1057-1068.
16. Berkun Y, Levatovsky D, Rubinow A et al. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 2004; 63: 1227-1231.
17. Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A. Metylene tetrahydrofolate reductase polymorphisms and methotrexate: no associaiton with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Clin Exp Rheumatol 2009; 27(3): 499-502.
18. Hughes LB, Beasley TM, Patel H, et al. Racial or ethnic differences in allele frequencies of single nucleotide polymorphisms in the methylene tetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1213-1218.
19. Van Ede AE, Laan RF, Blom HJ, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate- related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 2001; 44: 2525-2530.
20. Lee YH, Song GG. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis. Clin Drug Investig 2010; 30(2): 101-108.
21. Haagsma CJ, Blom HJ, van Riel PL, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58: 79-84.
22. Kurzawski M, Pawlik A, Safranow K, Herzynska M, Drozdzik M. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis. Pharmacogenomics 2007; 8(11): 1551-1559.
23. Stamp LK, Chapman PT, O'Donnell JL, et al. Polymorphisms within the folate Pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenet Genomics 2010; 20(6): 367-376.
24. Mena JP, Salazar-Paramo M, Gonzalez-Lopez L, et al. Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases. Pharmacogenomics J 2011; 11: 287-291.
25. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
26. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990; 33: 121-130.
27. Van der Heijde DM, van 't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-920.
28. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005; 23(5 Suppl 39): 14-18.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215-1217.
30. Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology 2004; 43: 267-271.
31. Morgan SL, Baggott JE. Folate supplementation during methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol 2010; 28(5 Suppl 61): 102-109.